Skip to main content
Offcanvas
Some text as placeholder. In real life you can have the elements you have chosen. Like, text, images, lists, etc.
What are you looking for?

 

The Syneos Health Insights Hub generates future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment.

  • Commercialization

2026 Dealmakers' Intentions Survey

Feb 18, 2026

Learn more about the expectations of biopharma decision makers in this forward-looking assessment of dealmaking activity for the year ahead.
  • CNS/Neuroscience

Rewriting the Rules of Psychiatry Drug Development: Measurement, Psychedelics and the Future of CNS Strategy

Mar 05, 2026

Explore how measurement innovation, psychedelic development and value strategy are reshaping psychiatric drug development and CNS clinical trials.

Download Now
  • Commercialization

The Syneos Health Podcast | Conversations on Commercialization

May 01, 2026

A limited series unpacking how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  
  • Commercialization

FT Live | Trends in Strategic Launch Investment

May 30, 2025

This video presentation discusses the latest insights on strategic launch investments and the impact of pre-launch spend on commercial success.
  • Commercialization

Biopharma BD Report | Q1 2025

May 27, 2025

Explore key Q1 2025 biopharma deal trends, including mergers and acquisitions activity, IPO performance and rising investor interest in obesity and neuroscience.
  • Site and Patient Engagement

WEBINAR | From Fragmentation to Integration: How Unified Technology Transforms Site Efficiency

May 15, 2025

This on-demand webinar explores what truly matters to sites and how technology can support, not slow down, their critical work.
  • Clinical Trial Acceleration
  • Oncology
  • Regulatory

Syneos Health Podcast | Project Optimus Series

May 14, 2025

In our latest episode, experts discuss how model-informed strategies, exposure-response analysis and biomarkers are transforming early phase trials.
  • Medical Affairs

Challenging the Status Quo: Evolving Medical Affairs Through a Capability-Centric Model | Japanese Perspective

May 14, 2025

Medical affairs leaders need to start thinking broadly about how to transform the function from a traditionally supporting role to one that is truly a strategic thought partner if...
  • Commercialization
  • Medical Affairs

Trends in Strategic Launch Investments

May 08, 2025

Get expert insights on strategic launch investments, smarter planning and AI-driven strategies – plus a bonus download to guide your 2025 launch success.
Interested in Syneos Health®?